Similar articles for PMID: 18794269

Year	Number of Results
1957	1
1958	2
1967	1
1970	1
1979	1
1991	1
1997	1
1998	1
1999	1
2000	8
2001	1
2002	7
2003	11
2004	9
2005	18
2006	23
2007	39
2008	58
2009	31
2010	12
2011	23
2012	15
2013	10
2014	16
2015	16
2016	5
2017	7
2018	6
2019	5
2020	4
2021	8
2022	5
2023	1
2024	0

1

Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.

Uesaka D, Demura Y, Ishizaki T, Ameshima S, Miyamori I, Sasaki M, Fujibayashi Y, Okazawa H. Uesaka D, et al. J Nucl Med. 2008 Oct;49(10):1606-12. doi: 10.2967/jnumed.108.051250. Epub 2008 Sep 15. J Nucl Med. 2008. PMID: 18794269 Free article.

2

Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.

Zytoon AA, Murakami K, El-Kholy MR, El-Shorbagy E, Ebied O. Zytoon AA, et al. Eur J Radiol. 2009 Jun;70(3):530-8. doi: 10.1016/j.ejrad.2008.01.045. Epub 2008 Apr 18. Eur J Radiol. 2009. PMID: 18395387

3

18F-FDG PET/CT for staging of penile cancer.

Scher B, Seitz M, Reiser M, Hungerhuber E, Hahn K, Tiling R, Herzog P, Reiser M, Schneede P, Dresel S. Scher B, et al. J Nucl Med. 2005 Sep;46(9):1460-5. J Nucl Med. 2005. PMID: 16157528 Free article. Clinical Trial.

4

FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.

Ohtsuka T, Nomori H, Ebihara A, Watanabe K, Kaji M, Naruke T, Suemasu K, Uno K. Ohtsuka T, et al. Ann Thorac Cardiovasc Surg. 2006 Apr;12(2):89-94. Ann Thorac Cardiovasc Surg. 2006. PMID: 16702929 Clinical Trial.

5

Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.

Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, de Klerk JM, Oyen WJ, Meijer S, Hoekstra HJ. Bastiaannet E, et al. J Clin Oncol. 2009 Oct 1;27(28):4774-80. doi: 10.1200/JCO.2008.20.1822. Epub 2009 Aug 31. J Clin Oncol. 2009. PMID: 19720925

6

Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.

Li M, Wu N, Liu Y, Zheng R, Liang Y, Zhang W, Zhao P. Li M, et al. Eur J Radiol. 2012 Aug;81(8):1886-90. doi: 10.1016/j.ejrad.2011.03.074. Epub 2011 Apr 20. Eur J Radiol. 2012. PMID: 21511421

7

18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.

Anjos DA, Etchebehere EC, Ramos CD, Santos AO, Albertotti C, Camargo EE. Anjos DA, et al. J Nucl Med. 2007 May;48(5):764-70. doi: 10.2967/jnumed.106.036350. J Nucl Med. 2007. PMID: 17475965 Free article. Clinical Trial.

8

[Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].

Cai L, Gao S, Li DC, Li YS, Chen QS, Xing XL. Cai L, et al. Zhonghua Zhong Liu Za Zhi. 2009 Feb;31(2):134-8. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19538892 Chinese.

9

Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.

Pelosi E, Pennone M, Deandreis D, Douroukas A, Mancini M, Bisi G. Pelosi E, et al. Q J Nucl Med Mol Imaging. 2006 Mar;50(1):15-22. Q J Nucl Med Mol Imaging. 2006. PMID: 16557200 Free article.

10

[Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].

Xu XX, Cheng J, Xu WG, Dai D, Song XY, Ma WC, Zhu L, Zhu X. Xu XX, et al. Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):364-8. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22883458 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

323 results

Results by year